Morgan Stanley Downgrades Alnylam Pharmaceuticals (ALNY) to Equalweight

January 14, 2014 6:51 AM EST Send to a Friend
Get Alerts ALNY Hot Sheet
Price: $91.72 +2.21%

Rating Summary:
    9 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 18 | New: 41
Trade ALNY Now!
Join SI Premium – FREE
Morgan Stanley downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Alnylam Pharmaceuticals click here. For more ratings news on Alnylam Pharmaceuticals click here.

Shares of Alnylam Pharmaceuticals closed at $66.21 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Morgan Stanley

Add Your Comment